https://mapk-inhibitor.com/ind....ex.php/medical-effec
To enhance our comprehension of the anti-psoriatic properties of AVX001, we sought to ascertain the way the chemical modulates swelling and keratinocyte hyperproliferation, key faculties of this psoriatic skin. We sized eicosanoid release from real human peripheral blood mononuclear cells (PBMC) and immortalized keratinocytes (HaCaT) and learned expansion in HaCaT grown as monolayers and stratified countries. We demonstrated that inhibition of cPLA2α using AVX001 produced a